Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Indust/Producer Dur Alphadex First Trust | FXR | Oct 30, 2024 | 76.34 | +0.07 |
Industrial Logistics Properties Trust | ILPT | Oct 30, 2024 | 3.65 | -7.12 |
Industrial Select Sector SPDR | XLI | Oct 30, 2024 | 135.39 | -0.17 |
Industrials ETF Vanguard | VIS | Oct 30, 2024 | 260.77 | -0.05 |
Infinera | INFN | Oct 30, 2024 | 6.74 | -0.74 |
InflaRx N.V | IFRX | Oct 30, 2024 | 1.57 | +0.32 |
Inflection Point Acquisition II | IPXX | Oct 30, 2024 | 10.79 | +0.09 |
Inflection Point Acquisition II Unit | IPXXU | Oct 30, 2024 | 10.86 | 0.00 |
Infobird | IFBD | Oct 30, 2024 | 1.90 | -2.56 |
Informatica | INFA | Oct 30, 2024 | 26.68 | -0.37 |
Information Services Group | III | Oct 30, 2024 | 3.14 | +0.96 |
Information Technology ETF Vanguard | VGT | Oct 30, 2024 | 602.32 | -1.31 |
Infosys ADR | INFY | Oct 30, 2024 | 21.12 | -2.99 |
InfuSystems | INFU | Oct 30, 2024 | 6.13 | -3.01 |
ING Group ADR | ING | Oct 30, 2024 | 16.79 | -0.89 |
Ingersoll Rand | IR | Oct 30, 2024 | 97.28 | +0.02 |
Ingevity | NGVT | Oct 30, 2024 | 41.65 | +17.92 |
Ingles Markets A | IMKTA | Oct 30, 2024 | 65.12 | +5.87 |
Ingram Micro Holding Corp | INGM | Oct 30, 2024 | 24.13 | 0.00 |
Ingredion | INGR | Oct 30, 2024 | 133.64 | +0.21 |
Inhibikase Therapeutics | IKT | Oct 30, 2024 | 2.77 | +4.92 |
Inhibrx Biosciences | INBX | Oct 30, 2024 | 16.29 | +1.18 |
InMed | INM | Oct 30, 2024 | 0.29 | +1.00 |
InMode | INMD | Oct 30, 2024 | 17.87 | -0.22 |
INmune Bio | INMB | Oct 30, 2024 | 5.95 | -5.56 |
Innate Pharma ADR | IPHA | Oct 30, 2024 | 1.83 | -1.08 |
Inno Holdings | INHD | Oct 30, 2024 | 3.86 | -1.78 |
Innodata | INOD | Oct 30, 2024 | 21.43 | -1.15 |
Innospec | IOSP | Oct 30, 2024 | 109.80 | +0.48 |
InnovAge | INNV | Oct 30, 2024 | 5.90 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.